Tuesday, October 6, 2026

COVID-19 vaccine makers BioNTech, AstraZeneca sued for damaging people’s health

It is unclear whether a judgment will be handed down on Monday. The parties may, however, reach a settlement.

• July 3, 2023
BioNTech, AstraZeneca covid vaccines and person vaccinated
BioNTech, AstraZeneca covid vaccines and person vaccinated

German courts on Monday will hear two civil cases against the manufacturers of coronavirus vaccines for allegedly damaging the health condition of some persons.

In one of the cases, the Regional Court in Rottweil in the south-western state of Baden-Württemberg is scheduled to hear the lawsuit brought by a 58-year-old man for damage to his health, which he attributes to a coronavirus vaccine from German firm BioNTech.

The man accuses the pharmaceutical company of being responsible for his suffering from a massive deterioration in the vision in his right eye due to the vaccination.

He is demanding €150,000 ($163,600) in compensation for his suffering.

In addition, the court is to determine if BioNTech is obliged to compensate for possible material damages.

The Mainz-based company considers the man’s accusation to be unfounded.

“We have carefully examined the health impairments presented by the plaintiff on the basis of all the information provided,” said a spokeswoman for the company.

A decision of the court is not expected on Monday.

Meanwhile, an appeal hearing in a case against AstraZeneca is also starting at the same time at the Higher Regional Court in Bamberg in Bavaria.

A regional court dismissed a woman’s lawsuit against the British-Swedish pharmaceutical company six months ago. The plaintiff, however, appealed against the ruling.

The woman had sued the company for damages after severe health complaints, which she attributed to a coronavirus vaccination, but the lawsuit was dismissed because the first court could find neither a product defect nor an information error.

It is unclear whether a judgment will be handed down on Monday. The parties may, however, reach a settlement.

The two civil cases are among the first against coronavirus vaccine manufacturers in Germany. 

(dpa/NAN)

We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.

More from Peoples Gazette

Nigerian Bar Association

States

Independence: NBA urges Nigerians to expect better future

The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.

farmers

Agriculture

FG tasks ECOWAS on leveraging financing strategies for agroecology

The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Katsina State

Politics

Katsina youths pledge to deliver over 2 million votes to Atiku

“Katsina State is Atiku’s political base because it is his second home.”

Politics

LG Elections: OYSIEC opens registration portal for ad hoc staff recruitment

Registration for the required positions will run from October 5 to October 20, 2026.

United States President Donald Trump

Diaspora

Trump moves to revoke U.S. citizenship of two Nigerians, 38 others

The prosecutors accused the 58-year-old of applying for immigration benefits under two different identities.

PRESIDENT BOLA AHMED TINUBU

Economy

Nigeria rises four places to eighth in 2026 Bloomberg Economics Investment Risk-O-Meter

The growth was attributed to the economic policies of the Tinubu administration.

Heading 4

Longest-serving Republican speaker Dennis Hastert, soiled by allegations of molesting high school athletes, dies at 84

The deceased, who was speaker from 1999 until 2007, was sentenced in 2016 to more than a year behind bars.

Taraba state governor, Darius Dickson Ishaku

Anti-Corruption

Witness reveals how funds were moved to private accounts in ex-Taraba governor’s trial

The judge adjourned the matter till October 6, 2026, for continuation of the evidence of PW3.

JAMB

Education

JAMB moves to adopt UTME centre in Canada for 2027

The board said the centre would enable eligible Nigerians living in Canada to take the UTME without travelling to Nigeria.